Updates in Oncology

Overview

 This conference is designed to efficiently discuss the most recent clinical advances in oncology.  It will address the questions that have emerged from the latest data presented at major international annual meetings.

 

Objectives

 At the completion of this conference, participants should be able to:

• Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of cancer patients

• Discern new data from key studies in clinical cancer research

• Explain clinical strategies designed to improve the quality of cancer care

• Identify tools for cancer risk assessment based on the best evidence

• Evaluate and recommend multidisciplinary treatment plans for cancer patients

 

Who Should Attend

This conference is designed for surgical oncologists, medical and radiation oncologists, radiologists, urologists, gastroenterologists, primary care physicians, dermatologists, pulmonologists, hematologists/oncologists, hematology/oncology fellows, oncology nurses, and other healthcare professionals involved in the treatment of patients with cancer.

 

Penn Medicine Faculty

Co-Chairs

Kevin R. Fox, MD

Marian T. and Robert J. MacDonald Professor, Medicine

Division of Hematology Oncology

Director, Rena Rowan Breast Center

 

Lynn M. Schuchter, MD

C. Willard Robinson Professor, Hematology Oncology

Chief, Division of Hematology Oncology

Program Leader, Melanoma and Cutaneous Malignancies

 

Faculty

Corey J. Langer, MD, FACP

Professor, Medicine

Division of Hematology Oncology

Director, Thoracic Oncology Program

 

Edward Stadtmauer, MD

Professor, Medicine

Division of Hematology Oncology

Director, Bone Marrow & Stem Cell Transplant Program

Leader, Hematologic Malignancies Program

 

Ursina R. Teitelbaum, MD

Assistant Professor, Medicine

Division of Hematology Oncology

 

David J. Vaughn, MD

Professor, Medicine

Division of Hematology Oncology

Director, Abramson Cancer Center's Clinical Research Unit